Curis (CRIS -3.8%) trades lower today, despite the company's earlier announcement that it's been...

|By:, SA News Editor

Curis (CRIS -3.8%) trades lower today, despite the company's earlier announcement that it's been issued a patent covering a genus of compounds that includes Debio 0932, an orally-administered Heat Shock Protein 90 inhibitor, which is being developed by Curis' licensee Debiopharm.